Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy
- 29 October 1998
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 339 (18), 1261-1268
- https://doi.org/10.1056/nejm199810293391801
Abstract
Combination antiretroviral therapy with indinavir, zidovudine, and lamivudine can suppress the level of human immunodeficiency virus (HIV) RNA in plasma below the threshold of detection for two years or more. We investigated whether a less intensive maintenance regimen could sustain viral suppression after an initial response to combination therapy.Keywords
This publication has 23 references indexed in Scilit:
- Mathematical Analysis of Antiretroviral Therapy Aimed at HIV-1 Eradication or Maintenance of Low Viral LoadsJournal of Theoretical Biology, 1998
- A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infectionAIDS, 1998
- Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panelJAMA, 1997
- Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 InfectionScience, 1997
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterThe New England Journal of Medicine, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994
- Population dynamics of HIV within an individual after treatment with zidovudineAIDS, 1991
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983